Few researchers and organisations have the expertise, skills, and infrastructure to tackle #AMR and discover new #antibiotics. Long-term funding for #antibiotic development partnerships will help attract young scientists to the field and keep companies in anti-infective drug development. To secure a sustainable future for efforts of this scale, we call on government leaders, the private sector and other stakeholders to invest in the development of antibiotics and AMR research. The AMR Accelerator is an Innovative Health Initiative (IHI) programme integrating nine projects with the shared goal of progressing the development of new antibiotics and building #antimicrobial resistance research capability. Five years in, we reflect on the programme’s value, results and key challenge: ensuring the sustainability of our assets, infrastructures and expertise. Read more in our article: https://lnkd.in/eqGbRqmg Explore our results: https://lnkd.in/ebSUbVhB
AMR Accelerator’s Post
More Relevant Posts
-
𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐂𝐞𝐧𝐭𝐫𝐢𝐟𝐮𝐠𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $2.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/d_ZHcYwN The growth of this market is driven by increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Thermo Fisher Scientific Danaher Corporation Eppendorf Kubota Corporation Sigma Laborzentrifugen GmbH Nuaire QIAGEN Andreas Hettich GmbH & Co. KG Hermle Schleiftechnik KG Sartorius Cardinal Health Centurion Scientific Ltd Bio-Rad Laboratories Agilent Technologies Haier Biomedical UK Antylia Scientific (Cole-Parmer INDIA PVT. LTD.) Heal Force Benchmark Scientific MEDITECH TECHNOLOGIES INDIA PRIVATE LIMITED Laby Instruments Industries NARANG MEDICAL LIMITED REMI Group Of Companies
-
-
The topline results are alarming. The decline in the size of the R&D #workforce adds further urgency to the already well-recognised need for greater investment in #amr.
We’ve long expressed our concern with how the lack of private investment in #AMR is hampering innovation and affecting the scientific workforce needed to move therapies from the lab bench to patient’s bedsides. Today the AMR Industry Alliance released a report exploring this issue and one statistic immediately jumps out in terms of highlighting the paucity of #AMR innovation: In 2022, there were approximately 20x more patents awarded for cancer-related research (2,388) than for antibiotics (115). Full report here: https://lnkd.in/eYz3bmjw
-
-
Are you attending ISPOR US 2024? Visit our stand and have a chat with Andrew Mumford and Luciana Strait and the team. They're eager to exchange insights and discuss how Initiate can assist in all of your Health Economics and Market Access needs. Alternatively if you can't wait for the conference, contact us at hello@initiateconsultancy.com #ISPORUS2024 #ISPOR #HealthEconomics #MarketAccess #Pharma #Networking
-
Head, Global Regulatory Affairs - (CoE) Emerging Technologies, Devices, and Combination Products & Volwiler Senior Research Industry Fellow - Regulatory Science, AbbVie Inc.
#DIA2025 Here is your chance to be part of the agenda in Washington, DC. (June 15-19, 2025) Our Track Chairs have highlighted priority topics within their educational tracks to provide direction on the content they would like to receive via the Call for Abstracts. You can submit abstracts addressing priority topics and/or topics relevant to the DIA 2025 track descriptions. Open Date: August 8, 2024 Close Date: September 12, 2024 We will accept abstracts for sessions, forums, workshops, and short courses. For more information, or to submit, please visit: https://lnkd.in/ebtzUP22 Questions? Contact DIA at AnnualMeetingProgram@DIAglobal.org I am on the program committee for Personalized Medicine, Combination Products, and Diagnostics Track 6. Here is our specific call for abstracts for priority topics in the picture below. #precisionmedicine,#personalizedmedicine, #bioethics, #diagnostics, #companiondiagnostics,#device,#digitalhealth,#combinationproducts,#ATMP,#advancedtherapies
-
-
🌟 Another Successful Webinar Completed! 🌟 Yesterday, Heredity Biosciences hosted an insightful webinar on "Nanotoxicity: A Challenge for Future Medicines." A huge thank you to Dr. Piyush Kumar Gupta 🇮🇳 for delivering an exceptional talk and sharing valuable insights. We're also grateful to all our active participants for their enthusiastic engagement and contributions to the discussion. 🎥 If you missed the live session, don't worry! You can now watch the recording at your convenience. Click the link below to access the webinar recording: [https://lnkd.in/gSXssW3r) Don't miss out on this opportunity to learn and stay informed about the latest developments in nanotoxicity research. Watch the recording today and enhance your knowledge in this important field. #Nanotoxicity #FutureMedicine #HeredityBiosciences #WebinarRecording #Science #Research #LearningOpportunity #hereditybio
-
-
We’ve long expressed our concern with how the lack of private investment in #AMR is hampering innovation and affecting the scientific workforce needed to move therapies from the lab bench to patient’s bedsides. Today the AMR Industry Alliance released a report exploring this issue and one statistic immediately jumps out in terms of highlighting the paucity of #AMR innovation: In 2022, there were approximately 20x more patents awarded for cancer-related research (2,388) than for antibiotics (115). Full report here: https://lnkd.in/eYz3bmjw
-
-
NBI Biosciences is a REVOLUTIONARY COMPANY working with plant actives to produce game changing new therapeutic medicines for CHRONIC DISEASES. It is driven by its vision of efficacy, safety and ease of use for therapies of major chronic diseases, including diabetes, cardiovascular diseases, and neurodegeneration, merging nature’s power with scientific innovation. The global biodiversity is our platform for opportunities which craft a stable and exciting future for design and delivery of therapeutic medicine. PLANT ACTIVES unlock nature’s healing potential, and our agriculture consultants pay heed to all aspects such as sustainable harvesting, obtaining quality plants, strong testing protocols for consistent quality and a vision that delivers medicine to world populations. Most long chain molecules in plants inherently have reduced or NO side effects. #DiabetesAwarenessMonth #OralInsulin #InnovationInHealth #Diabetes #NBI #Biotech #HealthAwareness #Internationaldiabetesfederation #PlantBasedDrugs #DrugDeliveryTechnology #FunctionalNeurologicalDisordersSociety #ParkinsonsFoundation #WIPO #USPTO
-
-
"𝐁𝐢𝐨𝐛𝐚𝐧𝐤𝐬: 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐚𝐧𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡" | 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 : https://lnkd.in/df-pVXNQ 🌱 Unlocking the Future of Medicine with Biobanks! 🌱Global Insight Services Biobanks are revolutionizing the way we approach healthcare and research. By storing and providing access to vast amounts of biological data, they are accelerating the development of personalized medicine, enhancing drug discovery, and driving breakthroughs in disease prevention. 🚀 As the demand for advanced medical solutions continues to grow, the biobanks market is poised for unprecedented expansion. Are you ready to be part of this transformative journey? 🌍 #biobanks #personalizedmedicine #healthcareinnovation #biotech #genomics #medicalresearch #precisionmedicine #lifesciences #drugdiscovery #clinicalresearch #healthcaretech #datascience #futureofhealthcare #diseaseprevention #medicalinnovation
-
-
Biochemist | Researcher | Sequencing Expert | Statistical Analyst | Microscopy
I am excited and thrilled to share my experience in the 8th IUBMB congress whose theme was Enhancing interdisciplinary partnership in Biochemistry and Biotechnology across Africa. It was such an insightful conference,no one mentions how engaging it can get when you attend a conference and the key note speakers are professors and doctors My key take homes were: - [x] How climate change is contributing to Antimicrobial resistance by promoting the suitable environment for the new strains to thrive and promoting epidemic outbreaks which result in extensive use of antibiotics - [x] The role of the pharmaceutical industry in manufacturing drugs that can be taken for short periods instead of very extensive periods - [x] How environment pollution is also a key contributor to AMR Please share your thoughts on key promoters of AMR - [ ] Another key take home was the use of AI intelligence in revolutionizing the healthcare system I want to pass my special regards to Dr.Clarence Mang’era who enabled us to attend the congress and the Kenya Monetary School of Studies for hosting the congress.
-
-
Hi #connections, "Excited to share my latest publication on [EVALUATION OF THE HEPATOPROTECTIVE ACTIVITY OF FORMULATION CONTAINING ANDROGRAPHOLIDE ON HEPATOTOXICITY INDUCED ALBINO WISTAR RAT], This study delves into [hepatpprotective activity] and offers valuable insights for [relevant industry/field]. I'd love to hear your thoughts and discuss further! #Research #Publication #Science", Here is the link: https://lnkd.in/gFNRpi3q
-
Incredibly important work! We hope to see your program grow and reach its goals! It is crucial to raise awareness and tackle AMR now, and we promise to do our part as well.